Costs and outcomes of atypical antipsychotics for the treatment of acute schizophrenia

被引:0
|
作者
Leeuwenkamp, O. [1 ]
Morlock, R. [2 ]
Bell, C. F. [3 ]
Brogan, A. [4 ]
Mauskopf, J. [4 ]
机构
[1] NV Organon, NL-5340 BH Oss, Netherlands
[2] Pfizer Inc, Ann Arbor, MI USA
[3] GlaxoSmithKline Inc, Memphis, TN USA
[4] RTI Hlth Solut, Res Triangle Pk, NC USA
关键词
D O I
10.1016/S1098-3015(10)65094-2
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A301 / A301
页数:1
相关论文
共 50 条
  • [1] Atypical antipsychotics in the treatment of schizophrenia
    Bridler, R
    Umbricht, D
    [J]. SWISS MEDICAL WEEKLY, 2003, 133 (5-6) : 63 - 76
  • [2] Atypical antipsychotics in the treatment of schizophrenia - Reply
    Geddes, J
    Harrison, P
    Freemantle, N
    Bebbington, P
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2001, 322 (7291): : 927 - 928
  • [3] Service use and costs of treating schizophrenia with atypical antipsychotics
    Lewis, M
    McCrone, P
    Frangou, S
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (10) : 749 - 756
  • [4] Impact of atypical antipsychotics on outcomes of care in schizophrenia
    Joyce, AT
    Harrison, DJ
    Loebel, AD
    Ollendorf, DA
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2005, 11 (08): : S254 - S261
  • [5] Acute phase of schizophrenia: impact of atypical antipsychotics
    Azorin, JM
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2000, 15 : S5 - S9
  • [6] ATYPICAL ANTIPSYCHOTICS FOR SCHIZOPHRENIA IN BRAZIL: A DESCRIPTIVE ANALYSIS OF ACQUISITION COSTS
    Mosca, M.
    Schneiders, R. E.
    Zimmermann, I. R.
    Alexandre, R. F.
    do Nascimento Jr, J. M.
    Gadelha, C. A.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A65 - A66
  • [7] Treatment of suicidal risks in schizophrenia with atypical antipsychotics
    Timotijevic, IT
    Stefanovic, LS
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S246 - S246
  • [8] New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression
    Orzelska-Gorka, Jolanta
    Mikulska, Joanna
    Wiszniewska, Anna
    Biala, Grazyna
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)
  • [9] Atypical antipsychotics in treatment-resistant schizophrenia
    Schäfer, I
    Lambert, M
    Naber, D
    [J]. NERVENARZT, 2004, 75 (01): : 79 - 89
  • [10] Comparative clinical efficacy of atypical antipsychotics and haloperidol in treatment of acute schizophrenia relapses
    Eremin, AV
    Kuzavkova, MV
    Mosolov, SN
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S132 - S132